Introduction {#s1}
============

Air pollution is a major global environmental risk factor of morbidity and mortality across the human lifespan ([@bib37]; [@bib57]; [@bib20]). Air pollution exposure is also associated with neurodegeneration, accelerated cognitive decline of aging and increased risk of Alzheimer's disease (AD) ([@bib35]; [@bib6]). However, little is known of interaction of air pollution neurotoxicity for sex and *APOE* alleles and other AD risk factors ([@bib21]).

Epidemiological studies of air pollution neurotoxicity have not identified interactions of gender by *APOE* alleles. Findings are typically 'adjusted or controlled' for gender differences ([@bib14]; [@bib11]; [@bib1]; [@bib23]). In the WHIMS cohort of elderly women, *APOE4* homozygotes had a greater risk of dementia and accelerated cognitive decline ([@bib3]). The *APOE*4 vulnerability for accelerated cognitive aging was recently extended to ozone, as well as PM10 and PM2.5 in a large sample of both sexes from New York City ([@bib35]). A recent study from China suggested greater male vulnerability to air pollution for verbal test deficits ([@bib73]). Sex-*APOE* interactions for air pollution neurotoxicity remain undefined. In a small sample from polluted Mexico City, *APOE4* heterozygous females with high BMI had higher risk of severe cognitive deficit than other groups ([@bib7]). Developmental air pollution exposure has received greater attention for gender because of the consistent male excess vulnerability for behavioral and cognitive deficits in the pre-adolescent and young adult ([@bib13]; [@bib59]).

Mouse models have not addressed sex and *APOE* in responses to air pollution. Our initial study examined female EFAD (*APOE*-TR/5xFAD-Tg^+/-^) mice carrying transgenes for familial AD genes (5xFAD) together with human *APOE* alleles by targeted replacement (*APOE*-TR), which had *APOE-*e3^+/+^ (E3; *APOE3*) or *APOE-*e4^+/+^ (E4; *APOE4*) genotype. Consistent with WHIMS findings, E4FAD female mice accumulated more brain amyloid in response to nPM than the E3FAD ([@bib3]). However, for ozone exposure, male *APOE*-TR showed the converse of greater behavioral impairments in *APOE3* than *APOE4* ([@bib30]). For further study of both sexes, we examined the cerebral cortex transcriptomic responses of *APOE*-TR and wildtype mice (C57BL/6J) by RNAseq for the main regulators of air pollution toxicity in AD pathways.

We focused on genomic pathways mediated by NRF2 and NFKB, which responded to air pollution in our prior studies ([@bib70]; [@bib65]). These redox-sensitive transcription factors control hundreds of genes that mediate cellular responses to oxidative stress and immunity. They respond to oxidative stress, tobacco smoke, traumatic brain injury, and ischemic stroke, and are altered by aging and AD ([@bib58]). NRF2 downstream genes include antioxidants (e.g. glutathione, thioredoxin), anti-inflammatory cytokines (e.g. IL10), phase I and II xenobiotic detoxifying enzymes (e.g. CYP450) and free radical scavengers ([@bib55]). The NFKB family transcriptionally regulates the expression of immune related proteins including cytokines (e.g. TNFA, IL1A, IL1B), antigen presentation proteins (e.g. MHCI, β2-microglobulin), chemokines (e.g. MCP1, MIP1), adhesion molecules (e.g. ICAM1, VCAM1), inducible nitric oxide synthase (INOS), and proapoptotic (e.g. BIM, BAX) or antiapoptotic proteins (e.g. XIAP, BCL2) ([@bib28]). The complex interplay of NRF2 and NFKB signaling pathways can alter the balance of anti-oxidative or inflammatory responses, depending on the type of stress, and target cell or tissue ([@bib58]).

Sex and *APOE* alleles can also alter NRF2 and NFKB activities, as shown for the larger response of female mice for hepatic NRF2 activation by phenobarbital and oxazepam and other xenotoxins ([@bib53]). NRF2 downstream genes including *Gsta2*, *Ho1*, and *Nqo1* showed lower hepatic expression in *APOE*4-TR than *APOE*3-TR mice ([@bib24]). We therefore examined both sex and *APOE* allele for interactions with NRF2/NFKB responses of air pollution neurotoxicity.

Results {#s2}
=======

To define brain transcriptional responses of air pollution and interactions with sex and *APOE* alleles, we examined responses of adult C57BL/6J (wild type, 'B6') and B6 mice carrying human *APOE3* and *APOE4* alleles by targeted replacement (*APOE*-TR) to nPM, a subfraction of ultrafine PM (PM0.2). Three independent exposures used different batches of nPM at specified durations of exposure (details on sample collection and chemical composition in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and [@bib74]). In vitro studies on BV2 microglia examined the role of NRF2 and NFKB in responding inflammatory pathways.

Cerebral cortex transcriptome responses to nPM {#s2-1}
----------------------------------------------

Differentially expressed genes (DEGs) were analyzed by RNAseq for nPM responses. Stratification by *APOE* and sex was done subsequently to establish general effects. The multivariate model of combined B6 and *APOE*-TR data was adjusted statistically for sex, *APOE* genotype, and different nPM batches of the two exposures. For p=0.005, there were 140 DEGs (118 increased, 22 decreased) responses to nPM ([Figure 1A](#fig1){ref-type="fig"}). Ingenuity pathway analysis (IPA) of responding pathways included synapse function (e.g. axonal guidance, calcium signaling, endocannabinoid neuronal synapse), inflammation (e.g. AMPK, SAPK/JNK), circadian rhythm, NRF2 mediated antioxidant response, and hypoxia-inducible factor 1-α (HIF1A) signaling ([Figure 1B](#fig1){ref-type="fig"}). The top DEGs include *Grin1* (+20%) and *Rap1a* (−20%) ([Figure 1C](#fig1){ref-type="fig"}).

![Cerebral cortex transcriptome responses to nPM in B6 and *APOE*-TR mice.\
(**A**) Multivariate differential expression analysis of nPM responses in combined data from the independent exposures of C57BL/6J (**B6**) and *APOE*-TR. Covariates included sex, *APOE* genotype, and nPM. DEGs identified at p-value, 0.005. (**B**) Canonical pathways associated with nPM DEGs. (**C**) Examples of nPM associated DEGs. (**D**) Sex- and *APOE*-stratified DE and WGCNA modules associated with nPM responses. Male, M; Female, F. The top 150 genes of modules (kME inter-module connectivity) were used for IPA analysis. Significance was calculated from the Pearson correlation of eigengene of the modules with nPM. (**E**) Upstream regulators and F) canonical pathways associated with nPM transcriptome responses in B6 and *APOE*-TR mice. Solid horizontal lines separate responses that are shared and sex-specific. Heatmaps were sorted by the sum of -log10 (p-values) in each row. p-values\<10^−6^ were converted to 10^−6^ for better visualization; grey, not significant. RNAseq sample size was 4/genotype/sex/treatment.](elife-54822-fig1){#fig1}

RNAseq data were stratified to identify sex- and *APOE*-specific nPM responses by linear models and by weighted gene co-expression (WGCNA). Females had more DEG than males for both B6 and *APOE*-TR mice, by up to two-fold ([Figure 1D](#fig1){ref-type="fig"}). Females of *APOE*3 and B6 had the most nPM responding genes (153 vs 189, respectively). Gene modules identified by WGCNA also had more female responses to nPM for B6 and *APOE*-TR ([Figure 1D](#fig1){ref-type="fig"}). Modules were constrained to a maximum of 150 hub genes, based on connectivity (Materials and methods). Both analyses (DE, WGCNA) showed more nPM-responding gene responses for *APOE*3 than *APOE4*.

Upstream regulators and canonical pathways were identified by IPA for sex-specific and shared nPM responses. The top upstream candidate was *Nfe2l2* (*Nrf2*), a regulator of Phase II detoxification ([Figure 1E](#fig1){ref-type="fig"}, [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}), which had the strongest associations for B6 and *APOE*4. Sexes differed in immune-related upstream regulators of gene responses. Female-specific responses included *Pparg* (peroxisome proliferator activated receptor gamma), *Sp1* (specificity protein1 transcription factor), and *Tnfsf11* (TNF superfamily 11). Male-specific responses included *Traf6* (TNF associated receptor factor 6), *Camk2* (regulator of synaptic plasticity and AMPA glutamate receptors), and *Ccdc22* (regulator of NFKB signaling by interaction with COMMD proteins). These results paralleled the enrichment of NRF2 and immune response pathways in the combined multivariate model above. 

Stratified analysis by *APOE* and sex for canonical pathways showed nPM responses of neuronal pathways; for example G-protein-coupled receptors, axonal guidance, ephrin receptors, synaptic long-term depression, and endocannabinoid development neuron pathway ([Figure 1F](#fig1){ref-type="fig"}). Other nPM responding genes were related to relaxin, GM-CSF, and c-AMP-mediated signaling. Female-specific responses include genes associated with the following pathways: AMPK, dopamine-PARPP32 feedback in cAMP, gap junction signaling, and nitric oxide production. Male-specific responses in both mouse strains were enriched for 'cardiac hypertrophy' signaling; for example, *Elk1* (transcription factor) and *Hsp27* ([Figure 1F](#fig1){ref-type="fig"}). *APOE*3 and *APOE4* of both sexes had different inflammatory responses for NFKB, IL6, CREB, and IL22 pathways ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Cell-type deconvolution analysis of RNAseq also showed *APOE* and sex-specificity for microglial and astrocyte responses to nPM ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}).

Baseline effects of *APOE4* allele and the overlap with nPM responses {#s2-2}
---------------------------------------------------------------------

Baseline differences by *APOE* in non-exposed controls were analyzed by sex in two steps. The combined multivariate model showed 133 DEGs differed in baseline *APOE* allele effect (5% FDR) ([Figure 2A](#fig2){ref-type="fig"}). These DEGs were enriched for immune-related pathways including rheumatoid arthritis, granulocyte adhesion, IL10, and NFKB signaling. *APOE4* baseline differences included pathways of glutamate metabolism, and production of nitric oxide, superoxide and hydrogen peroxide, the LXL/RXR pathway of cholesterol efflux, and atherosclerosis.

![*APOE* allele baseline differences of RNA in cerebral cortex.\
(**A**) Differential expression analysis of *APOE*4- vs *APOE3-*TR, at 5% FDR and p-value, 0.005. (**B**) WGCNA modules associated with *APOE4* allele. IPA of the top 150 genes of the modules identified by kME (inter-module connectivity). Significance was calculated from the Pearson correlation of eigengenes for modules with *APOE4* allele. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001; \*\*\*\*p\<0.0001. IPA analysis of overlapped genes between baseline differences by *APOE* allele and nPM response in females (**C**) and males (**D**). The genes in each group are a combination of identified genes based on DE and WGCNA. RNAseq sample size was 4/genotype/sex/treatment. Detailed IPA analysis of *APOE* allele baseline DEGs ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).](elife-54822-fig2){#fig2}

In stratified analysis, males had 60% more DEGs differing by *APOE* alleles (male, 75 genes; female, 45 genes ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). For WCGNA modules differing by *APOE* alleles, males had 3-fold excess (male 12 modules; female, four modules). Subsets of DEG (females, 70 DEGs; males, 37) had 7% overlap with nPM responding genes ([Figure 2C--D](#fig2){ref-type="fig"}), suggesting convergent effects of *APOE4* allele and nPM. For females, the shared responding genes involved metabolic pathways (glycolysis, oxidative phosphorylation) and DNA repair (HMGN1). The male overlap involved a different set of genes related to iron homeostasis, telomere extension, and immune response (TREM1, IL11, JAK signaling).

AD-related pathways differed by sex and *APOE* alleles for nPM responses ([Figure 3A--B](#fig3){ref-type="fig"}). Only female *APOE3* responded to nPM in five AD pathway genes for amyloid precursor protein (APP) processing and for tau: *App*, *Bace1*, *Psen1* ([Figure 3A](#fig3){ref-type="fig"}); *Tau* and *Gsk3b* ([Figure 3B](#fig3){ref-type="fig"}). In contrast to mRNA changes in amyloidogenesis genes, the levels of amyloid peptides (Aβ40 and Aβ42) were not affected by nPM exposure in the cerebral cortex of APOE-TR mice ([Figure 3C](#fig3){ref-type="fig"}). However, Aβ40 peptide had a 50% lower baseline in males than females of both *APOE3* and *APOE4*-TR mice ([Figure 3C](#fig3){ref-type="fig"}). Aβ40 peptide also had a significant negative correlation with mRNA levels of amyloidogenesis pathway including *App* (r, −0.65) and *Psen1* (r,−0.51 to −0.67) for both *APOE3* and *APOE4*-TR cerebral cortex ([Figure 3D](#fig3){ref-type="fig"}).

![AD-associated gene responses to nPM in cerebral cortex.\
(**A**) Amyloidogenic pathway responses. Female *APOE3* had largest nPM response. (**B**) *Tau* and its kinase, *Gsk3b*. (**C**) Levels of Aβ40 and Aβ42 peptides did not respond to nPM. However, females had higher Aβ40 (pg/ml) of both *APOE*3 and *APOE4* mice. \*\*p\<0.01, \*p\<0.05 in t-test. (**D**) Aβ40 peptide was negatively correlated with amyloidogenesis gene expression including App (r = −0.65), and Psen1 (r = −0.51 to −0.67). The expression was reported as Log2 count per million (cpm). (**E**) Aβ-amyloid clearance pathway responses to nPM. A small subset (10%, 5/46) of amyloid clearance genes differed by *APOE* or nPM (genes identified in the IPA database for phagocytosis, proteolysis, degradation, deposition). Only *APOE*3 responded to nPM. Mean ± SEM. ANOVA; FDR multiple test correction. \* Adj. p-value, 0.05. Sample size: 4/genotype/sex/treatment.](elife-54822-fig3){#fig3}

About 10% of genes related to amyloid clearance (5/46) differed by *APOE* or nPM. For amyloid clearance genes, only *APOE3* carriers in both sexes responded to nPM ([Figure 3E](#fig3){ref-type="fig"}). Three genes responded to nPM with sex differences only in *APOE3*. For *APOE3* females, *Vav2* (+50%); *Vav3* (decreased −50%); the Vav guanine nucleotide exchange factors mediate phagocytosis of fibrillar Aβ ([@bib64]). For *APOE3* males, *S100a9* (−60%), also known as *Mrp14*, regulates microglial phagocytosis of fibrillar Aβ ([@bib36]). Baseline expression of two complement genes was higher in *APOE3* than *APOE4: C3* (10-fold), *C3ar1* (+50%).

Sex- and *APOE*- specific nPM-mediated NFKB responses {#s2-3}
-----------------------------------------------------

Next, we examined genes of the NFKB pathway, which regulate pro-inflammatory responses to nPM, as shown for responses of wildtype mice (B6 males) in hippocampus to nPM ([@bib65]). In cerebral cortex, *APOE*-TR mice responded to nPM with a subset of genes downstream of NFKB (13%, 8/133) that differed by sex and *APOE* ([Figure 4A](#fig4){ref-type="fig"}). Two clusters of nPM responses were identified by Principal Component Analysis for these 133 NFKB downstream genes: Principal component (PC) 2 (20% of variance, nPM: sex interaction) and PC4 (2.5% of variance nPM:*APOE4* interaction) ([Figure 4B](#fig4){ref-type="fig"}).

![nPM induced inflammatory responses with sex- and *APOE* specificity.\
(**A**) Stratified analysis of NFKB downstream genes responses to nPM. The combined IPA datasets included 133 NFKB downstream genes. (**B**) Principal component analysis of 133 NFKB downstream genes in *APOE*-TR: PC2 (20% of total variance) was associated with nPM: sex interaction; PC4 (2.5% of variance), associated with nPM:*APOE* interaction. (**C**) Protein levels of genes downstream of NFKB were correlated with PC2: positive correlations for CXCL1 and IL1B; inverse correlation with TNFA. Only females responded to nPM. Sample size of 4/genotype/sex/treatment.](elife-54822-fig4){#fig4}

Cytokine protein levels were examined for association with these PCs in cerebral cortex. PC2, but not PC4, was correlated with TNFA (r = −0.39, p=0.02), IL1B (r = 0.51, p=0.002), and CXCL1 (r = 0.43, p=0.01) proteins ([Figure 4C](#fig4){ref-type="fig"}). Only females responded to nPM for these cytokines. These RNA and protein responses are notable for consistent sex-specific inflammatory responses to nPM.

Sex- and *APOE* allele-specific NRF2 responses {#s2-4}
----------------------------------------------

NRF2 downstream responses to nPM differed by sex and *APOE* ([Figure 5A](#fig5){ref-type="fig"}). The 60 responding genes included *Gpx3*, and *Gstp1*, *Jun*, *Nfe2l1* (*Nrf1*), and several *Maf* family transcription factors. A subset of gene responses was validated by qPCR, for example *Nrf1* ([Figure 5B](#fig5){ref-type="fig"}; [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Female B6 and *APOE*-TR had 2-fold or more *Nrf2* downstream genes responding to nPM. PC2 is associated with nPM for interactions with sex (p=0.01) and *APOE* (p=0.02), 6.4% of the variance, mainly associated with *APOE3* females ([Figure 5C](#fig5){ref-type="fig"}). The strong inverse correlation of *Nrf2* PC2 with *Nfkb* PC2 ([Figure 5E](#fig5){ref-type="fig"}, r = - 0.95, p=0.0001) suggests crosstalk between these transcriptional factors during exposure to nPM.

![*Nrf2* responses to nPM in B6 and *APOE*-TR mice.\
(**A**) Heatmap of log2 fold changes of nPM responses, showing altered expression of at least 60 genes downstream of *Nrf2*, differing by sex or *APOE* genotype. (**B**) Validation by qPCR of *Nfe2l1* (*Nrf1*) changes in RNAseq. (**C**) Principal component analysis of 513 *Nrf2* downstream genes in *APOE*-TR: Only PC2 (6.4% of variance) had nPM-sex interaction (p=0.01) and *APOE* (p=0.02). *APOE3* females had the highest nPM response. (**D**) PC2 of *Nrf2* downstream genes varied inversely (R2 = 0.91, p=0.0001) with the PC2 of *Nfkb* downstream genes. Sample size of 4/genotype/sex/treatment.](elife-54822-fig5){#fig5}

Inhibitory effects of NRF2 on NFKB response to nPM {#s2-5}
--------------------------------------------------

The relationship of NRF2 and NFKB responses of nPM was further explored in an independent dose-response experiment. The duration of inhalation exposure was only 3 weeks to assess the initial responses of nPM by male C57BL/6 mice. After 3-week exposure to 300 μg/m^3^ nPM, the cerebral cortex had nuclear translocation of NRF2 protein (+50%) and increased cytosolic NFKBP65 (+25%) ([Figure 6A](#fig6){ref-type="fig"}). Downstream of NRF2, the rate limiting enzyme of glutathione synthetase (GCLC) had dose-dependent increase correlated with *Nrf2* mRNA (r, 0.6, p=0.005) ([Figure 6B](#fig6){ref-type="fig"}). *Nrf2* and *Nfkb* responses of B6 male mice at three nPM doses had opposing changes of increased *Nrf2* mRNA, but decreased *Nfkbp65*, *Nfkbp50* mRNA and IL2 protein, all with dose-dependence ([Figure 6C](#fig6){ref-type="fig"}).

![NRF2 and NFKB interact with nPM toxicity in cerebral cortex of male C57BL/6 mice and in mouse microglia (BV2 cells, in vitro).\
(**A**) Increased nuclear translocation of NRF2 and cytosolic NFKBP65 of B6 mice exposed to 300 μg/m^3^ nPM for three wks. (**B**) nPM exposure dose-dependent increase of *Nrf2* mRNA and positive correlation with increase of GCLC protein. (**C**) nPM dose-dependent decrease of *Nfkbp65* and *Nfkbp50* mRNA, and IL2 protein levels. Inhalation exposure to nPM at 100, 200, and 300 μg/m^3^ nPM (in vivo sample size, 10/group; exposure, 5 hr/d, 3 d/wk, 3 wks. \*\*p=0.001, \*\*\*p=0.0001. (**D**) BV2 microglia in vitro response to nPM at 5 μg/ml nPM for 6 hr after partial knockdown of *Nrf2* (sample size, 6/group; two independent biological replicates). *Nrf2* mRNA knockdown was \>60% at time 0. ANOVA with FDR multiple test correction. Mean ± SEM. \*Adj. p=0.05. nPM chemical characterization ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).](elife-54822-fig6){#fig6}

Nrf2 and Nfkb interactions were examined in BV2 microglia in vitro during acute (6 hr) exposure to nPM. Partial knockdown of *Nrf2* (−40%) by siRNA increased the *Nfkb* mediated responses of nPM ([Figure 6D](#fig6){ref-type="fig"}), with 30% higher *Nfkbp50* mRNA, and 200% higher mRNA of *Inos*, *Il1b* and *Il6*.

NRF2 and NFKB are potential regulators of the nPM responses in the cerebral cortex and mixed glial culture {#s2-6}
----------------------------------------------------------------------------------------------------------

The top canonical pathways related to nPM exposure in the cerebral cortex of adult mice comprised of calcium signaling, HIF1α signaling, circadian rhythm pathway, AMPK signaling, SAPK/JNK signaling, endocannabinoid pathways and NRF2 oxidative stress responses ([Figure 1A](#fig1){ref-type="fig"}). These highly interconnected pathways comprise a larger network of oxidative and inflammatory responses ([Figure 7](#fig7){ref-type="fig"}). Thus, the hub regulators of nPM responses could broadly affect these pathways. Using IPA analysis, we built two networks from the NRF2 and NFKB downstream genes in the identified canonical pathways. Exposure to nPM caused expression changes in four of these genes in the cerebral cortex of adult mice: *Smarca4* (+25%), *Cftr* (+25%), *Hdac1* (−65%), and *Vegfc* (−65%).

![NRF2 and NFKB are potential upstream regulators of the top canonical pathways related to nPM effects in the cerebral cortex of adult mice.\
Gene networks of (**A**) NRF2 and (**B**) *NFKB* downstream genes in the top nPM related canonical pathway ([Figure 1A](#fig1){ref-type="fig"}). The network was made by IPA software. The networks were overlaid with the significant responses to nPM in mixed glial culture ([@bib65]). The numbers indicate log2 fold-changes of gene expression in Affymetrix microarray. Dataset from prior studies ([@bib65]). In vitro sample size, 4/group.](elife-54822-fig7){#fig7}

We hypothesized that these networks are among the initial responses to nPM exposure and contributed to chronic damage at later stages. The transcriptional responses of these networks were examined in mixed glial culture after 24 hr exposure to 10 μg/ml nPM (Dataset from prior nPM studies [@bib65]). Major increases of both *Nrf2* (300%) and *Nfkb* (400%) mRNA were induced by acute nPM exposure ([Figure 7](#fig7){ref-type="fig"}). A large portion of genes from the constructed networks was also upregulated by nPM: 17 NRF2 and 30 NFKB DEGs from these downstream networks. These genes were related to all selected signaling pathways: HIF1A, calcium, AMPK, SAPK/JNK, and the endocannabinoid system. Several of these genes are also transcriptional regulators that could initiate further downstream changes, body-wide. Some of these genes include *Brca1* (+30%), *Atf4* (350%), *Smarca4* (50%), *Hif1a* (400%), and *Stat3* (350%) ([Figure 7](#fig7){ref-type="fig"}).

Discussion {#s3}
==========

These finding address the gap in how sex and *APOE* allele interactions may alter neurodegenerative responses to air pollution. Cerebral cortex genomic responses to nPM, were examined in C57BL/6 mice (B6, wildtype) and B6 mice carrying human transgenes for *APOE*3 and *APOE*4 alleles. Female mice had two-fold more genes that responded to nPM, further enhanced for *APOE*3. Responding genes included neuronal pathways (e.g. axonal guidance; glutamate synapse genes), inflammation (e.g. AMPK, and APK/JNK signaling), and antioxidant and hypoxic signaling (e.g. NRF2, HIF1A signaling). Genes in pathways downstream of NFKB and NRF2 responded oppositely to nPM. These interactions of NRF2 and NFKB may modulate sex and *APOE* risk for AD and accelerated cognitive aging during air pollution exposure.

The nPM responding genes may help to identify GxE in neurodegenerative risks from air pollution and cigarette exposure. For example, a combination of air pollution and a specific *IL1B* variant increased the risk of Parkinson disease ([@bib40]). Our findings extend microarray analysis of frontal cortex of children and young adults from Mexican cities differing in air pollution levels: the 134 responding genes include inflammation (e.g. *NFKB*) and antioxidant responses (e.g. *GPX2*, *GPX3*) ([@bib5]). Microarray analysis of rat brain chronically exposed to PM0.2 also overlapped with our results: *S100a9*, calcium channels (e.g. *Cacna1i*), and glutamate receptors ([@bib42]).

These glutamatergic gene responses extend findings that hippocampal neurites are selectively sensitive to nPM ([@bib48]; [@bib66]; [@bib22]). The increased levels of the ionotropic receptor NMDA type subunit 1 (*Grin1*) is notable: a *GRIN* polymorphism is associated with the risks of Parkinson ([@bib67]), schizophrenia ([@bib18]), and also interacts with *APOE* alleles for earlier AD onset ([@bib17]), *GRIN* variants might also alter air pollution neurodegenerative responses, for example mutations in *GRIN2A* and *GRIN2B* increased the risk of cognitive impairments for lead poisoning of children ([@bib54]). The nPM responses of *Grin2a* and *Grin2b* mRNA, while modest (p=0.05--0.06), merit further study among xenobiotics.

AD-associated genes responded differently to nPM by sex and *APOE* allele. *APOE3* females had the lowest baseline and the highest nPM response in genes associated with amyloidogenesis and TAU. The smaller responses of *APOE*4 mice to nPM may be a ceiling effect, because about 7% of the nPM responsive genes also had *APOE4* baseline differences in both sexes. For non-exposed controls (baseline), *APOE4* vs *APOE3* differed in 300 genes related to known *APOE* pathways including LXR/RXR ([@bib15]), Atherosclerosis ([@bib44]), and Rheumatoid arthritis ([@bib60]). A similar *APOE* allele specificity was found in responses to ozone (O~3~), which impaired memory in *APOE3*, but not *APOE4*-TR mice ([@bib30]). This pattern may be compared with ceiling effects of aging on responses to air pollution which we observed in middle-aged B6 mice. Both sexes at age 18 months have elevated baseline levels of antioxidant and inflammatory gene mRNA and protein, which did not respond to nPM or O3, unlike young mice ([@bib30]; [@bib66]; [@bib71]).

Brain amyloid must also be considered in the complex interactions of APOE genotype and sex with air pollution. The current study of *APOE*-TR mice response to nPM and a study of response to ozone ([@bib30]) showed that neither air pollutant altered brain Abeta40 and Abeta42 peptide levels for mice of ages 3 to 18 months (young to middle-age). The *APOE*-TR mice have the normal murine wildtype amyloid peptide Abeta42, which differs from the human in three amino acids and aggregates less avidly ([@bib49]). Thus, our study in *APOE*-TR mice do not include additional stress due to amyloid aggregates present in the *FAD* transgenic models. Unlike *APOE*-TR, nPM exposure increased the amyloid plaque loads in EFAD (*APOE*-TR plus five mutation in amyloidogenic genes) and *J20* AD mouse models ([@bib3]; [@bib4]). In EFAD mice, nPM caused greater amyloid plaque load in E4FAD than E3FAD. Even in that study, nPM increased levels of Abeta oligomers, but not plaque load in E3FAD more than for E4FAD mice. These differences suggest the hypothesis that *APOE* alleles cause differences in amyloid clearance, phagocytosis, and proteolysis. As expected, some nPM-responding genes that mediate amyloid clearance differed by the *APOE* allele. The complement factor C3, which mediates amyloid clearance ([@bib45]), had a higher baseline in *APOE*3, but lacked nPM response, whereas *Vav* and S100 calcium-binding protein A9 (*S100a9*) responses to nPM were restricted to *APOE*3. *Vav* and *S100a9* regulate phagocytosis of fibrillary Abeta by microglia ([@bib64]; [@bib36]). The *APOE*3 and 4 proteins, and Abeta compete differentially for uptake by astrocytes via the lipoprotein receptor-related protein 1 (LRP1)-dependent pathway ([@bib62]). Moreover, *APOE*4 astrocytes have less efficient Abeta clearance, attributed to acidification of endosomes ([@bib62]; [@bib52]). Possibly, an efficient clearing system could compensate even for a greater amyloidogenic effect of nPM in *APOE3* than *APOE4* mice. This hypothesis will be tested further in vitro and in vivo.

Similar to the amyloid pathway, *APOE4* had higher baseline level of inflammation, while their response to nPM was less than the *APOE3*. This allele specificity was also shown for responses to ozone ([@bib30]). In contrast, responses to LPS endotoxin by intra-peritoneal injection were greater in *APOE4* male mice for microglial activation and systemic inflammatory cytokines ([@bib75]). In vitro, *APOE*4 macrophages also had higher induction of NFKB, TNFA, and heme oxygenase one in response to LPS ([@bib31]). While air pollution can include endotoxins, the comparisons with injected LPS for sex and *APOE* are limited because the systemic responses are downstream of the lung, which receives most inhalants.

Female mice had greater response to nPM than males for immune and antioxidant pathways, for wildtype and *APOE*-TR mice. Sex hormones and early life gonadal programming during brain development could underly these differences. Ex-vivo microglial cultures from male and female brains had divergent inflammatory response to estradiol (E2) and LPS ([@bib43]). A gene expression microglial developmental index showed a sex difference in maturation and immune reactivity, which correlated with the risk of AD and autism spectrum disorders ([@bib27]). In SH-SY5Y neuroblastoma cells, E2 increased cell survival and NRF2 antioxidant defense against homocysteine ([@bib10]). Similarly, E2 treatment of postnatal rats ameliorated acute ethanol-induced oxidative stress, neuroinflammation, and neuronal cell death through increase of sirt1, P53 acetylation inhibition, and reduction in phospho-NFKB nuclear localization ([@bib33]). Higher adaptive genomic response by females might favor faster detoxification or recovery from air pollution. Metformin mediated NRF2 activation could ameliorate tight junction proteins, blood--brain barrier (BBB) integrity, reduce inflammation and oxidative stress, and also normalize the levels of BBB glucose transporter GLUT1 protein after cigarette smoke exposure in mice ([@bib51]).

As opposed to potential protective effects of estrogen hormones against air pollution, female mice had higher baseline levels of Abeta40 than males. This results parallels with female excess amyloid plaque load of aged AD mouse models ([@bib8]; [@bib29]). Neonatally demasculinized or defeminized *3xTg*-AD or other AD transgenic mice shows the major role of sex steroids in determining adult sex differences in Abeta accumulation ([@bib9]; [@bib50]). Thus, sex steroids can act as a double-edged sword for amyloidogenic responses to air pollution and other environmental neurotoxins. Resolving the role of steroid hormones in this intricate relationship of background biology and air pollution requires studies on the recovery after nPM exposure in gonadectomized and older mice. We plan further studies of the complex interface of sex-*APOE* allele and nPM in mixed glial cultures derived from male and female *APOE3* and *APOE4*-TR mice.

NFKB and NRF2 had opposite responses to nPM, that included downstream genes in wildtype B6 and *APOE*-TR. This divergence was also shown in a short term (3 weeks) exposure of B6 male mice. The NRF2 and NFKB crosstalk was validated in BV2 microglia. This is the first evidence for NRF2 and NFKB interactions in response to air pollution of both in vivo and in vitro models. These results parallel the LPS responses of monocytes, which showed redox-mediated transcriptional cross-talk between NRF2 and NFKB responses to LPS ([@bib72]). Concurrent increase of nuclear NRF2 and cytosolic NFKBP65 in cerebral cortex after nPM exposure suggest that NRF2 activation can attenuate NFKB nuclear localization. We hypothesize involvement of KEAP1, the NRF2 repressing protein, which can mediate IKKB degradation and inhibit NFKB nuclear localization ([@bib34]; [@bib39]). Other mechanisms could be mediated by direct protein-protein interaction, and by secondary messengers. For example, NRF2 can inhibit NFKB through reduction of reactive species and suppress RAC1-mediated NFKB activation ([@bib56]; [@bib16]). In contrast, NFKB can also inhibit NRF2 activity through enhancing the recruitment of histone deacetylase (HDAC3) to ARE region ([@bib63]), or competing with NRF2 for binding to CH1-KIX domain of CBP protein inside the nucleus ([@bib41]). These interactions are also shown for thein nematode *C. elegans:* the *NRF2* homologue *skn-1* and the antibacterial factor 2 (*abf-2*) responded rapidly to nPM, with persisting developmental effects ([@bib25]).

Since immortalized BV2 microglial cells have limited comparability with in vivo microglial cells, we further corroborated the nPM responses of adult brain in primary mixed glial culture. In adult brain, nPM affected a network of genes from a set of highly interconnected canonical pathways including NRF2 oxidative stress response, HIF1A, AMPK, circadian rhythm, and endocannabinoid related signaling pathways. Interestingly, numerous genes from this network including *Nrf2* and *Nfkb* mRNA were upregulated in mixed glial culture after 24 hr acute exposure to nPM. A large portion of this gene network were considered as downstream of NRF2 and NFKB transcriptional factors. Thus, these two molecules are potentially the hub upstream regulators of long-term nPM neurotoxic effects. This hypothesis remained to be tested in further in vitro and in vivo studies.

The statistical power to identify all responding genes is intrinsically limited by the high dimensionality of RNAseq data with \>20,000 genes. Thus, p=0.05 threshold needs to be adjusted for multiple testing to identify the real changes. Unfortunately, the small effect size of nPM exposure together with the necessarily small sample size of animals led to lack of enogh power to detect the changes at 5% FDR rate. To minimize the rate of false positives, we reported the changes at a nominal significance of p\<0.005. Nonetheless, there could be small changes in some genes that we could not detect but still critical for air pollution toxicity. For example, while RNAseq analysis did not detect responses of *Nrf2*, *Nfkb*, and *Gclc* mRNA at p\<0.005, the nPM dose-response experiment showed a 50% dose-dependent change in *Nrf2*, *Nfkb* mRNA, and GCLC protein, which confirmed findings on the cerebellum ([@bib70]). Thus, RNAseq and other high dimensional data are inherent with potential false-positive and false-negative results.

Another limitation of air pollution studies is the heterogeneity in the chemical composition and toxic activity PM. Recently, we identified physical and chemical characteristics of nPM that altered in vitro and in vivo toxicity of nPM ([@bib74]; [@bib26]). Regardless, NRF2 and NFKB responses were consistent in all the nPM batches used in these different experiments.

In summary, air pollution neurotoxicity was shown to have sex- and *APOE* allele-specificity, which are main risk factors for AD. These findings give a rationale for including *APOE*-gender interactions in epidemiological studies of cognitive aging and dementias.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                               Designation                                    Source or reference                                           Identifiers                                                                          Additional information
  (species) or resource                                                                                                                                                                                                                         
  ------------------------------------------- ---------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------------------------------ ----------------------------------
  Genetic reagent (*M. musculus*)             *APOE3*-TR^+/+^\                               PMID:[8980023](https://www.ncbi.nlm.nih.gov/pubmed/8980023)                                                                                        
                                              *APOE4*-TR^+/+^                                                                                                                                                                                   

  Strain, strain background (*M. musculus*)   C57BL/6J (B6)                                  Jackson laboratory                                            000664; RRID:[IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664)       

  Cell line (*M. musculus*)                   BV2 microglia                                  ATCC                                                          EOC 20 (ATCC CRL-2469); RRID:[CVCL_5745](https://scicrunch.org/resolver/CVCL_5745)   Female originated

  Other                                       Mixed glia (microglia and astrocyte)           *R. norvegicus*                                                                                                                                    Postnatal days 3--5, mixed sexes

  Transfected construct (*M. musculus*)       *Nfe2l2* siRNA                                 Thermofisher Scientific                                       156499                                                                               

  Other                                       Lipofectamine RNAiMAX reagent                  Thermofisher Scientific                                       13778500                                                                             

  Antibody                                    anti-NRF2 (rabbit polyclonal)                  Abcam                                                         ab137550; RRID:[AB_2687540](https://scicrunch.org/resolver/AB_2687540)               WB, 1:1000

  Antibody                                    anti-H3 (rabbit polyclonal)                    Cell Signaling Technology                                     D1H2; RRID:[AB_10544537](https://scicrunch.org/resolver/AB_10544537)                 WB, 1:1000

  Antibody                                    anti-GAPDH (Mouse monoclonal)                  Santa Cruz Biotechnology                                      sc-32233; RRID:[AB_627679](https://scicrunch.org/resolver/AB_627679)                 WB, 1:500

  Antibody                                    anti-NFKBP65 (Rabbit polyclonal)               Cell Signaling Technology                                     D14E12; RRID:[AB_10859369](https://scicrunch.org/resolver/AB_10859369)               WB, 1:750

  Antibody                                    anti-mouse IRDye 800CW                         LICOR                                                         926--32210; RRID:[AB_621842](https://scicrunch.org/resolver/AB_621842)               WB, 1:20,000

  Antibody                                    anti-rabbit IRDye 680RD                        LICOR                                                         926--68070; RRID:[AB_10956588](https://scicrunch.org/resolver/AB_10956588)           WB, 1:20,000

  Commercial assay or kit                     RNAeasy Mini Kit                               Qiagen                                                        74104                                                                                

  Commercial assay or kit                     TRUseq Stranded mRNA Kit                       Illumina                                                      20020594                                                                             

  Commercial assay or kit                     qScript cDNA Supermix                          Quantabio                                                                                                                                          

  Commercial assay or kit                     Taq master mix                                 Biopioneer                                                    MAT-2.1--10                                                                          

  Commercial assay or kit                     12--230 kDa Jess or Wes Separation Module      Protein Simple                                                SM-W004                                                                              

  Commercial assay or kit                     V-PLEX proinflammatory panel one immunoassay   Mesoscale Diagnostics, Rockville, MD                          K15048D                                                                              

  Commercial assay or kit                     V-PLEX Aβ Peptide Panel 1 (4G8) Kit            Mesoscale Diagnostics, Rockville, MD                          K15199E                                                                              

  Chemical compound, drug                     TRIzol                                         Invitrogen                                                    15596026                                                                             

  Software, algorithm                         Rstudio                                                                                                                                                                                           Packages: LIMMA, WGCNA, BRETIGEA

  Software, algorithm                         Ingenuity pathway analysis                     Qiagen                                                                                                                                             

  Software, algorithm                         GraphPad Prism                                                                                                                                                                                    Version 8
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

Husbandry and experimental procedures were approved by the USC Institutional Animal Care and Use Committee (approval numbers: *APOE*-TR experiment, 20417; B6 experiments and mixed glial culture, 11233). The C57BL/6J and *APOE*-TR ([@bib68]) mice were aged 2 months at exposure onset ([@bib2]; [@bib69]). For long-term nPM exposures (8--15 weeks), four mice for each sex, genotype (C57BL/6J, *APOE*3-TR, *APOE*4-TR), and exposure (48 mice total) were randomly assigned to nPM exposure or control. The dose-response experiment was done with 10 male C57BL/6J mice per group. After exposure, mice were euthanized by isoflurane anesthesia and perfused transcardially with phosphate-buffered saline. Brains were hemisected at midline; total cerebral cortex was frozen on dry ice and stored at −80°C. Investigators were blinded to exposure groups during data measurement and analyses.

Air pollution nPM collection and exposure {#s4-2}
-----------------------------------------

Mice were exposed to nPM, a nano-sized subfraction of airP particulate matter of 2.5 microns diameter (PM2.5) collected from a local urban freeway corridor ([@bib66]; [@bib26]). Briefly, PM0.2 samples were collected by a High-Volume Ultrafine Particle (HVUP) Sampler ([@bib47]) at 400 L/min flow rate on an 8 × 10 inch-Zeflour PTFE filter (Pall Life Sciences, Ann Arbor, MI). The Particle Instrumentation Unit of University of Southern California is located within 150 m downwind of a major freeway (I-110). Chemical composition and size distribution of re-aerosolized nPM is characterized by high-resolution mass spectrometry (SF-ICPMS) and Sievers 900 Total Organic Carbon Analyzer as described before ([@bib48]; [@bib26]). Chemical characterization of the nPM batches in this study is in Supplementary data ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Re-aerosolized nPM or filtered air (control) was delivered to the sealed exposure chambers at approximately 300 μg/m3 concentration to model chronic exposure: 5 h/day, 3 days/week, for 8 (C57BL/6J) or 15 weeks (*APOE*-TR). For dose-response experiment, 8 weeks male C57BL/6J mice were exposed to approximately 100, 200, and 300 μg/m^3^ for 3 weeks. The duration and nPM dosages were based on brain responses in prior studies ([@bib26]; [@bib12]). The 3 weeks of intermittent exposure (5 h/day, 3 days/week) to 300 μg/m^3^ nPM yields an average hourly exposure of 27 μg/m^3^, as experienced in many cities.

RNA sequence (RNAseq) analysis of mouse cerebral cortex {#s4-3}
-------------------------------------------------------

RNA was extracted with TRIzol (Invitrogen) and RNAeasy Mini Kit (Qiagen) with DNase digestion. Libraries were made with the TRUseq Stranded mRNA Kit (Illumina) with 1 mg of RNA. For Illumina NextSeq500sequencing, a single end-sequencing length of [\>]{.ul}50 nt was used. Reads were aligned and quantified to the mouse reference genome RefSeq mm10 with Tophat2 (v2.0.8b), restricted to uniquely mapping reads with three possible mismatches using the Partek flow software platform ([@bib61]).

Differential gene expression was calculated by linear modeling (Limma package in R). Significance was calculated at 5% FDR rate or p-value, 0.005. Gene responses were analyzed by Qiagen Ingenuity Pathway Analysis (IPA) software. In combining the datasets generated from B6 and *APOE*-TR experiments, the models were adjusted by the COMBAT method to control for unknown variance ([@bib32]). Additional downstream analysis and plotting were done in Rstudio and GraphPad Prism. Cell type deconvolution analysis was done using BRETIGEA (BRain cEll Type specIfic Gene Expression Analysis) R package ([@bib46]), which uses single-cell RNAseq data to identify cell-type-specific gene-signatures to predict the proportion of each cell type in bulk RNAseq data.

Weighted gene co-expression network analysis (WGCNA) {#s4-4}
----------------------------------------------------

The co-expression network, based on WGCNA, was constructed from RNAseq data. WGCNA is an unsupervised clustering approach, which assigns groups of genes with shared expression patterns into modules ([@bib38]). Briefly, the adjacency matrix (correlations between genes) was converted to a scale-free network using soft threshold power (tuned in each group) of the signed matrix. The result was converted to a topological overlap matrix (TOM). Hierarchical clustering used 1-TOM distance measure (dissimilarity). A dynamic tree-cut algorithm was used to assign modules containing at least 30 genes. Module eigengenes (MEs) were calculated as the maximum amount of the variance of the model for each module, based on the Singular Value Decomposition method. Linear regression models estimated association of nPM or *APOE* with the MEs. The top 150 hub genes of the modules were selected for IPA analysis by the highest eigengene connectivity (kME). In total, 32 nPM associated gene modules were identified based on different analyses. Thus, the modules were renamed to M1-M32 to distinguish each analysis.

Cell culture and *Nrf2* siRNA {#s4-5}
-----------------------------

BV2 microglia (mouse-derived) were grown in Dulbecco's modified Eagle's medium (DMEM)/F12 (Cellgro, Mediatech, Herndon, VA) containing 10% fetal bovine serum, 1% penicillin/streptomycin, and 1% L-glutamine ([@bib65]). These cells were authenticated by expression of microglial markers, cell morphology, phagocytic activity, and comparison of nPM or LPS responses with mixed glial culture and other literature. The cells were not tested for mycoplasma. *Nfe2l2* (*Nrf2*) siRNA (156499, Thermofisher Scientific) was delivered by Lipofectamine RNAiMAX reagent (Thermofisher Scientific).

Quantitative real-time PCR {#s4-6}
--------------------------

Extracted RNA was reverse transcribed to cDNA using qScript cDNA Supermix (Quantabio). qPCR used Taq master mix (Biopioneer) and gene-specific primers ([supplementary file 1](#supp1){ref-type="supplementary-material"}; [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}).

Protein extraction {#s4-7}
------------------

Frontal cerebral cortex (anterior to Bregma, excluding olfactory bulbs) was homogenized (20 mg in 0.2 ml) in 1x RIPA buffer supplemented with 1 mM Na~3~VO~2~, 1 mM phenylmethane sulfonyl fluoride (PMSF), 10 mM NaF, phosphatase inhibitor cocktail (Sigma), and Complete Mini EDTA-free Protease Inhibitor Cocktail Tablet (Roche). Supernatants were obtained by centrifugation at 12,000 g/15 min.

NRF2 subcellular localization {#s4-8}
-----------------------------

Nuclear and cytosolic fractions were separated after tissue homogenization in sucrose-Tris-MgCl~2~ (STM) buffer with phosphatase and protease inhibitors and centrifuged 800g × 15 min ([@bib19]). After removing supernatant, the nuclear pellet was washed in STM buffer, resuspended in HEPES pH 7.9 buffer (20 mM HEPES 1.5 mM MgCl~2~, 0.5 M NaCl, 0.2 mM EDTA, 20% glycerol, 1% Triton-X-100, protease and phosphatase inhibitors) and sonicated. Cell fraction purity was validated by immunoblotting for nuclear histone 3 (H3) and cytosolic glyceraldehyde 3-phosphate dehydrogenase (GAPDH).

Protein analysis {#s4-9}
----------------

NRF2 was detected by Western blot using anti-NRF2 primary antibody (1:1000, rabbit polyclonal, ab137550). Proteins (20 μg) were electrophoresed on Criterion 4--15% TGX gels (Biorad) and transferred to PVDF membranes. After washing with TBS+0.05% Tween-20 (PBST), membranes were blocked (LiCOR) 1 hr/ambient, then incubated with primary antibody overnight at 4°C: anti-NRF2 (1:1000, rabbit polyclonal, ab137550), anti-NFKBP65 (1:750, Rabbit polyclonal, Cell Signaling Technology, D14E12), anti-H3 (1:1000, Rabbit polyclonal, Cell Signaling Technology, D1H2), and anti-GAPDH (1:500, Mouse monoclonal, Santa Cruz Biotechnology, sc-32233). Bands were identified by incubation with 1:20,000 fluorochome-conjugated LICOR-antibodies (anti-mouse IRDye 800CW or anti-rabbit IRDye 680RD); band intensity was analyzed by ImageJ. GCLC was assayed by capillary electrophoresis (12--230 kDa range, Jess ProteinSimple, California, USA). Total lysate 1 μg/μl was electrophoresed and treated with anti-GCLC (1:100) and HRP-labeled secondary antibody. Results were normalized to total protein (PN module, ProteinSimple). IL2 was assayed by V-PLEX proinflammatory panel one immunoassay (Mesoscale Diagnostics, Rockville, MD). Abeta 40 and 42 peptides were assayed by 4G8 Kit VPLEX (Peptide Panel 1, Meso Scale Discovery, Rockville, MD).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This interesting study addresses pressing questions about the interactions between sex and *ApoE* in response to nPM. The authors\' RNAseq data demonstrate various sex differences in response to nPM, as well as several genotype differences in response to nPM. The authors also show data suggesting that there is an interaction between *Nrf2* and *NFkB* in the nPM response.

**Decision letter after peer review:**

Thank you for submitting your article \"Mouse brain transcriptome responses to inhaled nanoparticulate matter differed by sex and *ApoE* in *Nrf2-NFkB* interactions\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by K VijayRaghavan as the Senior and Reviewing Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Riu-Ming Liu (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in *eLife* but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand or to explicitly state that the relevant conclusions require additional supporting data.

Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in *eLife*, either of which would be linked to the original paper.

Summary:

The etiology of Alzheimer\'s disease is unclear. This study explores the potential interactions between a genetic risk factor (*APOEe4*) and environmental exposure (particulate matter exposure) in the regulation of gene expression in the brain and sex effect, using human *ApoE* 3 and 4 replacement mice. Transcriptome responses to inhaled nanoparticulate matter were determined by RNAseq and partially confirmed by qPCR, using mouse brain tissues from wild type and *ApoE3* or 4 mice. The transcriptome data were analyzed by Weighted Gene Co-Expression Network Analysis (WGCNA) and Ingenuity Pathway Analysis (IPA) etc. software. Crosstalk between *Nrf2* and *NFkb* pathways was further studied using culture microglial cells. The study is significant and is innovative, as no such study has been reported yet. The methods used to analyze gene expression are standard and reliable. The results are interesting, although not completely surprising. However, some issues remain to be addressed.

Revisions for this paper:

Specific concerns:

1\) No information about the sample size is provided in any of the figures. It is unclear whether the transcriptome data are from one single run or whether the results have been repeated and how many samples have been used in each group.

2\) FDR values will be more convincing than p-values for analysis of RNAseq data. It is unclear why the p-value was set to 0.005, instead of 0.05, for DEGs.

3\) Figure 1 and 2, what M1...M32 stands for needs to be specified clearly.

4\) Figure 1 legend is messed up. Should C be D, D be E and E be F? The labels should be revised in the text as well.

5\) Figure 1---figure supplement 3, panel B. Materials and methods section should be detailed about how cell type deconvolution analysis of RNAseq was conducted. What genes have been used to identify these cells?

6\) Figure 3A shows clearly a sex and *ApoE* genotype dependent response to nPM in amyloid peptide (Ab) metabolism (synthesis and clearance). In *ApoE3* mice, males have higher expression levels of the genes involved in Ab synthesis than female mice under untreated condition. These data seem contradictory to published data, which show more Ab in females than in male. It is also interesting to notice that *ApoE4* mice express less Ab clearance related genes than *ApoE3* mice (C3 and C3ar1). It is strongly suggested to measure Ab levels in these mice to correlate to these gene expression profiles with Ab levels.

7\) Only female E3, not female E4, responded to nPM in Ab pathway genes. The potential mechanism need to be discussed.

8)Figure 4. PC2 and PC4 need to be defined.

9\) In general, E3 mice, both male and female, responded more drastically than E4 mice to nPM in *Nrf2* and *NFkb* pathways as well as Ab metabolism. These findings seem to be unexpected, based on the literature about *ApoE3* and *ApoE4* mice. What is the potential mechanism and biological significance needs to be discussed in details.

10\) The paper would be greatly strengthened by including a dose-response in female B6 mice, and performing in vitro *Nrf2*/*NFkB* experiments in microglia from female mice. As much of the paper focuses on sex differences in response to nPM, and Figure 4 shows clear sex differences in NF-κB responses to nPM, these should be extended to the experiments described in Figure 6. Ideally, the in vitro experiments should be repeated with primary microglia from male and female mice, rather than BV2 cells. This would also substantially increase the strength of the model proposed in the graphical abstract. Minimally, the authors need to address the caveats of the BV2 experiments in the Discussion.

11\) A rationale for the doses selected in the dose-response should be included in the paper; the lowest selected dose of 100ug/m3 nPM is still very high relative to typical human exposures. While it may not be feasible to repeat the dose-response studies, a more informative and typical dose response would likely include doses that differ by an order of magnitude i.e. 1, 10 and 100 μg/m3.

12\) The logic for focusing on *Nrf2* pathways based on the RNAseq data is not clear. Based on the IPA analysis shown in Figure 1B, the NRF-2 pathway appears much less affected than calcium, HIF1a, or AMPK signaling. While this may reflect the fact that *ApoE3*-TR mice did not appear to respond via Nfe2L2, it is somewhat surprising that the canonical *Nrf2*-mediated oxidative stress response pathway is implicated in the multivariate model (Figure 1B) but not the stratified pathway analysis (1F). Although there may be valid reasons to investigate NRF2 based on previous studies (as described in the Introduction), the RNAseq data in Figure 1 does not make a strong case for focusing on this pathway specifically. Likewise, it is not clear why genes identified by the RNAseq study (i.e. Grin1) are not investigated further. Are these genes downstream of *NFkB* or *Nrf2* in the in vitro microglia models?

13\) It is very interesting that amyloid deposition pathways were affected by nPM only in *ApoE* females. However, this would seem surprising, given that the authors previously saw increased amyloid deposition in E4FAD mice exposed to nPM compared to E3FAD mice. How do the authors reconcile the lack of AD-associated gene responses in female *ApoE4*-TR mice with their previous finding of increased amyloid deposition in female E4FAD mice exposed to nPM? This should be added to the Discussion.

14\) The interaction chosen is striking: sex and *ApoE3/4* genotype. It seems one among many possible experimental designs to impose and is justified in the Introduction in a somewhat miscellaneous fashion.

15\) About Abeta, only the *ApoE3* mice responded. Isn\'t that surprising?

16\) Subsection "Air pollution nPM collection and exposure" need more detail about the chemical engineering used to prepare the samples. And \"5 h/day, 3 days/week\" for 8 weeks does not sound like \"chronic exposure\" to me.

17\) Likewise, Results paragraph three: \"Both analyses (DE, WGCNA) showed more nPM-responding gene responses for *ApoE3* than *E4*.\" Isn\'t that surprising?

18\) In light of the senior author\'s long experience in genetics and molecular biology, it might be useful to use part of the Discussion to offer comments on the pathway analysis programs he uses: discussion of their epistomilogic status and the verity of the statistical analyses applied would head off charges of over-interpretation of the data presented here.

19\) There seem to be emerging new theories re the chemical status of nanoparticle/microcavity relations. Can the authors use this in their Discussion?
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Author response

> Revisions for this paper:
>
> Specific concerns:
>
> 1\) No information about the sample size is provided in any of the figures. It is unclear whether the transcriptome data are from one single run or whether the results have been repeated and how many samples have been used in each group.

The sample sizes were added to all figure legends.

> 2\) FDR values will be more convincing than p-values for analysis of RNAseq data. It is unclear why the p-value was set to 0.005, instead of 0.05, for DEGs.

Additional sentences were added to Discussion to explain why it is important to use a nominal significance level stronger than p 0.05. Discussion paragraph eleven.

> 3\) Figure 1 and 2, what M1...M32 stands for needs to be specified clearly.

A sentence was added to WGCNA methods to define M1-M32 names.

> 4\) Figure 1 legend is messed up. Should C be D, D be E and E be F? The labels should be revised in the text as well.

We apologize and corrected Figure 1 legend.

> 5\) Figure 1---figure supplement 3, panel B. Materials and method section should be detailed about how cell type deconvolution analysis of RNAseq was conducted. What genes have been used to identify these cells?

We added details and references to Materials and methods subsection "RNA sequence (RNAseq) analysis of mouse cerebral cortex". The markers are described in PMID29892006.

> 6\) Figure 3A shows clearly a sex and ApoE genotype dependent response to nPM in amyloid peptide (Ab) metabolism (synthesis and clearance). In ApoE3 mice, males have higher expression levels of the genes involved in Ab synthesis than female mice under untreated condition. These data seem contradictory to published data, which show more Ab in females than in male. It is also interesting to notice that ApoE4 mice express less Ab clearance related genes than ApoE3 mice (C3 and C3ar1). It is strongly suggested to measure Ab levels in these mice to correlate to these gene expression profiles with Ab levels.

We welcomed this opportunity to measure amyloid peptides. We obtained new data for the cerebral cortex of APOE-TR animals. See Figure 3 and subsection "Baseline effects of ApoE4 allele and the overlap with nPM responses".

> 7\) Only female E3, not female E4, responded to nPM in Ab pathway genes. The potential mechanism need to be discussed.

See discussion of mechanisms in paragraph four and five of the Discussion section.

> 8\) Figure 4. PC2 and PC4 need to be defined.

Principal components (PC) are defined in subsection "Sex- and ApoE- specific nPM mediated NFKB responses".

> 9\) In general, E3 mice, both male and female, responded more drastically than E4 mice to nPM in Nrf2 and NFkb pathways as well as Ab metabolism. These findings seem to be unexpected, based on the literature about ApoE3 and ApoE4 mice. What is the potential mechanism and biological significance needs to be discussed in details.

This result also surprised us. Further comparison with previous studies showed that this is a consistent pattern, Discussion paragraphs four and five. *ApoE4* allele elevated the baseline expression OF inflammatory and antioxidant genes. Thus, E4 MAY cause a ceiling effect in responsiveness to the environment. This is similar to the ceiling effect of age against nPM or O3 response. We added additional discussion points about this observation.

> 10\) The paper would be greatly strengthened by including a dose-response in female B6 mice, and performing in vitro Nrf2/NFkB experiments in microglia from female mice. As much of the paper focuses on sex differences in response to nPM, and Figure 4 shows clear sex differences in NF-κB responses to nPM, these should be extended to the experiments described in Figure 6. Ideally, the in vitro experiments should be repeated with primary microglia from male and female mice, rather than BV2 cells. This would also substantially increase the strength of the model proposed in the graphical abstract. Minimally, the authors need to address the caveats of the BV2 experiments in the Discussion.

We appreciate the reviewers' suggestion on studying sex-specific responses in mixed glial culture. We state our plans for a sex-specific mixed glial culture study, which will take us 6 to 9 months post COVID19. That said, we were able to honor the reviewers' suggestion with analysis of microarray dataset that was available from a prior study. This new analysis adds depth by further documenting the importance of *Nrf2*, NF-κB transcriptional factors in initial responses of nPM.

> 11\) A rationale for the doses selected in the dose-response should be included in the paper; the lowest selected dose of 100ug/m3 nPM is still very high relative to typical human exposures. While it may not be feasible to repeat the dose-response studies, a more informative and typical dose response would likely include doses that differ by an order of magnitude i.e. 1, 10 and 100 μg/m3.

During the past decade, our lab has tested a wide range of air pollution dosages in adult brains. The dosages were selected based on the observed neurotoxicity in our previous studies. these data suggest that the reviewer's proposed concentrations would have minimal effect on adult mouse brain. The 300 μg/m3 is used by other labs in experimental studies (PMID30668980, PMID29523932, PMID27865893). These levels are experienced by many populations in Asia and Africa. In our model, exposure for 5hr/day, 3day/week) for 3 weeks yields an average hourly exposure of 27 μg/m3 that is experienced in any US cities. We added information to Materials and methods to justify these dosages.

> 12\) The logic for focusing on Nrf2 pathways based on the RNAseq data is not clear. Based on the IPA analysis shown in Figure 1B, the NRF-2 pathway appears much less affected than calcium, HIF1a, or AMPK signaling. While this may reflect the fact that ApoE3-TR mice did not appear to respond via Nfe2L2, it is somewhat surprising that the canonical Nrf2-mediated oxidative stress response pathway is implicated in the multivariate model (Figure 1B) but not the stratified pathway analysis (1F). Although there may be valid reasons to investigate NRF2 based on previous studies (as described in the Introduction), the RNAseq data in Figure 1 does not make a strong case for focusing on this pathway specifically. Likewise, it is not clear why genes identified by the RNAseq study (i.e. Grin1) are not investigated further. Are these genes downstream of NFkB or Nrf2 in the in vitro microglia models?

We understand this concern. We added analysis in mixed glial culture transcriptome data to show the relationship of *NFkB* and *Nrf2* with other nPM related canonical pathways. Our new network analysis revealed that the top nPM related canonical pathway is highly interconnected. Moreover, *NFkB* and *Nrf2* are the upstream regulators of the numerous key regulators of all the highlighted pathways.

> 13\) It is very interesting that amyloid deposition pathways were affected by nPM only in ApoE females. However, this would seem surprising, given that the authors previously saw increased amyloid deposition in E4FAD mice exposed to nPM compared to E3FAD mice. How do the authors reconcile the lack of AD-associated gene responses in female ApoE4-TR mice with their previous finding of increased amyloid deposition in female E4FAD mice exposed to nPM? This should be added to the Discussion.

We suggest that the reason behind higher Abeta plaque accumulation in E4FAD mice is the higher clearance capacity of the animals with the E3 genotype. Our study of EFAD female mice showed that nPM induced more Abeta oligomer formation in E3FAD than E4FAD. However, this pattern did not hold for amyloid plaques. As shown by PMID29946028, PMID23620513, E3 mice and cells have faster clearance of amyloid peptides. We expanded the topic in the Discussion paragraph four and five.

> 14\) The interaction chosen is striking: sex and ApoE3/4 genotype. It seems one among many possible experimental designs to impose and is justified in the Introduction in a somewhat miscellaneous fashion.

Air pollution, sex, and *APOE* are among the major risk factors of late-onset of Alzheimer's disease, mortality, and many other chronic diseases. Few studies have tackled this three-way interaction, mostly like because of its daunting complexity. Even after two decades of *APOE* research, the reasons behind the sex heterogeneity of *ApoE4* effects remains unclear. We hope our analysis will encourage further study of GxE for *ApoE* and sex.

> 15\) About Abeta, only the ApoE3 mice responded. Isn\'t that surprising?

These results were unexpected, but lead us to seek a larger pattern of an *APOE4* ceiling effect. As noted above, this pattern was observed in other studies including O3 exposed *APOE*-TR animals.

> 16\) Subsection "Air pollution nPM collection and exposure" need more detail about the chemical engineering used to prepare the samples. And \"5 h/day, 3 days/week\" for 8 weeks does not sound like \"chronic exposure\" to me.

As suggested, additional information about the chemical characterization of nPM was added to the paper. Chemical data were also added to the supplement.

> 17\) Likewise, Results paragraph three: \"Both analyses (DE, WGCNA) showed more nPM-responding gene responses for ApoE3 than E4.\" Isn\'t that surprising?

While surprising, our data shows this consistently.

> 18\) In light of the senior author\'s long experience in genetics and molecular biology, it might be useful to use part of the Discussion to offer comments on the pathway analysis programs he uses: discussion of their epistomilogic status and the verity of the statistical analyses applied would head off charges of over-interpretation of the data presented here.

Additional discussion was added about the interconnectivity of the enriched pathway in paragraph ten of the Discussion section.

> 19\) There seem to be emerging new theories re the chemical status of nanoparticle/microcavity relations. Can the authors use this in their Discussion?

Additional discussion was added about confounding effects of chemical and physical characteristics of PM on air pollution toxicity in paragraph twelve.
